Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human prothrombin complex for hemophilia B bleeding
CTR20180229Phase 3Completed
- Sponsor
- Chengdu Rongsheng Pharmaceutical
- Start
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of prothrombin complex concentrate, human in hemophilia B (HB), sponsored by Chengdu Rongsheng Pharmaceutical. Started Jun 2018; status: completed.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20180229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180229.